These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 27216153)
1. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα. Jayaraman S; Doucet M; Lau WM; Kominsky SL Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA. Jayaraman S; Doucet M; Kominsky SL Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154 [TBL] [Abstract][Full Text] [Related]
3. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2. Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106 [TBL] [Abstract][Full Text] [Related]
4. Post-transcriptional control of Cited2 by transforming growth factor beta. Regulation via Smads and Cited2 coding region. Chou YT; Yang YC J Biol Chem; 2006 Jul; 281(27):18451-62. PubMed ID: 16675452 [TBL] [Abstract][Full Text] [Related]
5. Cited2 modulates TGF-beta-mediated upregulation of MMP9. Chou YT; Wang H; Chen Y; Danielpour D; Yang YC Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352 [TBL] [Abstract][Full Text] [Related]
7. CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells. Jayaraman S; Doucet M; Kominsky SL Oncol Lett; 2018 Jan; 15(1):871-878. PubMed ID: 29399152 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts. Zhu L; Zhang S; Huan X; Mei Y; Yang H Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350 [TBL] [Abstract][Full Text] [Related]
9. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance. Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783 [TBL] [Abstract][Full Text] [Related]
10. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029 [TBL] [Abstract][Full Text] [Related]
11. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. Jiang Q; Zhang H; Zhang P J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884 [TBL] [Abstract][Full Text] [Related]
12. CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer. van Agthoven T; Sieuwerts AM; Veldscholte J; Meijer-van Gelder ME; Smid M; Brinkman A; den Dekker AT; Leroy IM; van Ijcken WF; Sleijfer S; Foekens JA; Dorssers LC Br J Cancer; 2009 Dec; 101(11):1824-32. PubMed ID: 19904269 [TBL] [Abstract][Full Text] [Related]
13. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis. Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699 [TBL] [Abstract][Full Text] [Related]
14. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells. Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172 [TBL] [Abstract][Full Text] [Related]
15. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells. Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829 [TBL] [Abstract][Full Text] [Related]
16. High IKKα expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer. Bennett L; Quinn J; McCall P; Mallon EA; Horgan PG; McMillan DC; Paul A; Edwards J Int J Cancer; 2017 Apr; 140(7):1633-1644. PubMed ID: 28006839 [TBL] [Abstract][Full Text] [Related]
17. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390 [TBL] [Abstract][Full Text] [Related]
18. Enpp1: a potential facilitator of breast cancer bone metastasis. Lau WM; Doucet M; Stadel R; Huang D; Weber KL; Kominsky SL PLoS One; 2013; 8(7):e66752. PubMed ID: 23861746 [TBL] [Abstract][Full Text] [Related]
19. Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis. Li T; Lu H; Shen C; Lahiri SK; Wason MS; Mukherjee D; Yu L; Zhao J Oncogene; 2014 Sep; 33(39):4746-55. PubMed ID: 24096480 [TBL] [Abstract][Full Text] [Related]
20. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells. Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]